Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04280484 · ClinicalTrials.gov registry record · NA
Acute Intermittent Hypoxia in Persons With Multiple Sclerosis
A NA study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04280484 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 10 participants.
The verdict
NCT04280484, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The overall objective of this project is to investigate the effectiveness of Acute Intermittent Hypoxia (AIH), to improve muscle strength and activity level in individuals with relapsing-remitting MS.
Interventions
- OTHER Intermittent Hypoxia
- OTHER Sham Hypoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-06-18 |
| Est. Completion | 2019-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04280484
The ClinicalTrials.gov registry entry for NCT04280484 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intermittent Hypoxia is the first listed.
NCT04280484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04280484 about?
NCT04280484 is a clinical study titled "Acute Intermittent Hypoxia in Persons With Multiple Sclerosis". The overall objective of this project is to investigate the effectiveness of Acute Intermittent Hypoxia (AIH), to improve muscle strength and activity level in individuals with relapsing-remitting MS.
What is the current status of trial NCT04280484?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-06-18. Estimated completion is 2019-12-30.
What interventions are being tested in trial NCT04280484?
The interventions under investigation include: Intermittent Hypoxia (OTHER), Sham Hypoxia (OTHER).
Who is sponsoring clinical trial NCT04280484?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.